Add time:07/16/2019         Source:sciencedirect.com

AimsDietary related quality of life has not been previously explored with patients with type 2 diabetes using SGLT-2 inhibitors, the latest class of diabetes medications. The study sought to describe the patient experience on SGLT-2 inhibitors and examine if there are improvements in dietary perceptions and satisfaction with these drugs.

We also recommend Trading Suppliers and Manufacturers of 2-IT (cas 78853-38-0). Pls Click Website Link as below: cas 78853-38-0 suppliers